Article Details
Retrieved on: 2017-12-13 19:01:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Almost exactly two years ago, the venture firm <b>Andreessen Horowitz</b> took the wraps off a $200 million “biofund” that aimed to invest at the intersection of biology and engineering and was being led by its (then) new general partner, Vijay Pande. Pande argued at the time that it was finally possible to ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here